Australia Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute, contributing to its research goals in several ways: We provide operations teams to deliver clinical trials i.e. the (usually) randomized,…
Polymun Scientific 2012 marks the twentieth anniversary of Polymun. Can you describe to our readers the origins of the company and how it compares to your expectations in 1992? Prior to founding Polymun, I worked as a professor for the Institute of Applied Microbiology at the University of Natural Resources and Applied…
Health Sciences Authority HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite unique because we also run the national blood service and we have an Applied Sciences Group that looks into laboratory…
Schülke & Mayr Austria 2012 represents the 123rd anniversary of Schülke&Mayr. There have been many changes over the years, but do you think the ideals and values of today reflect the original vision set out by the founders in 1889? Generally, this is true. But of course, many things changed over the course of…
BioSingapore In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore and describe its main objectives? BioSingapore was created in 2004 by the Singapore Economic Development Board (EDB) to create an interactive platform for the…
Australia Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking, The George Institute for Global Health is an academic research organization that focuses on high impact clinical research. We do…
The George Institute For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT on neurotransmitters in the brain and the effects on blood pressure. From Boston I moved to Hammersmith hospital in London…
Rare Voices Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in 2011. Can you please begin with giving our readers an introduction to Rare Voices and explain to our readers why the organization was needed? It is estimated that there are disease community…
Sanofi China Among Big Pharma, Sanofi has a track record of placing a lot of faith in emerging markets – with local production, a large product portfolio, and decades of experience. As the largest and fastest-growing emerging market, what is the strategic importance of China to Sanofi? And, vice versa, where does…
Ottobock Mexico Can you give us a historical overview of the main milestones and achievements of Ottobock since it settled in Mexico in 1995? Ottobock was founded in 1919 by Doctor Ottobock in Germany, after the WWI. He was trying to address the many amputations that happened during the war, and started…
In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is going through globally: the country deals with patent cliffs, companies are cutting back staff, an ageing population forces the government to rethink healthcare expenditures, and big originator companies are restructuring. And…
Grupo Vitalmex Mexico Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at the center. We focus on a very specific strategy based on 3 goals: Accessibility, availability, and opportunity. There is clearly…
See our Cookie Privacy Policy Here
